Cargando…

DOT1L is a barrier to histone acetylation during reprogramming to pluripotency

Embryonic stem cells (ESCs) have transcriptionally permissive chromatin enriched for gene activation–associated histone modifications. A striking exception is DOT1L-mediated H3K79 dimethylation (H3K79me2) that is considered a positive regulator of transcription. We find that ESCs are depleted for H3...

Descripción completa

Detalles Bibliográficos
Autores principales: Wille, Coral K., Zhang, Xiaoya, Haws, Spencer A., Denu, John M., Sridharan, Rupa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656071/
https://www.ncbi.nlm.nih.gov/pubmed/37976354
http://dx.doi.org/10.1126/sciadv.adf3980
_version_ 1785148016562274304
author Wille, Coral K.
Zhang, Xiaoya
Haws, Spencer A.
Denu, John M.
Sridharan, Rupa
author_facet Wille, Coral K.
Zhang, Xiaoya
Haws, Spencer A.
Denu, John M.
Sridharan, Rupa
author_sort Wille, Coral K.
collection PubMed
description Embryonic stem cells (ESCs) have transcriptionally permissive chromatin enriched for gene activation–associated histone modifications. A striking exception is DOT1L-mediated H3K79 dimethylation (H3K79me2) that is considered a positive regulator of transcription. We find that ESCs are depleted for H3K79me2 at shared locations of enrichment with somatic cells, which are highly and ubiquitously expressed housekeeping genes, and have lower RNA polymerase II (RNAPII) at the transcription start site (TSS) despite greater nascent transcription. Inhibiting DOT1L increases the efficiency of reprogramming of somatic to induced pluripotent stem cells, enables an ESC-like RNAPII pattern at the TSS, and functionally compensates for enforced RNAPII pausing. DOT1L inhibition increases H3K27 methylation and RNAPII elongation–enhancing histone acetylation without changing the expression of the causal histone-modifying enzymes. Only the maintenance of elevated histone acetylation is essential for enhanced reprogramming and occurs at loci that are depleted for H3K79me2. Thus, DOT1L inhibition promotes the hyperacetylation and hypertranscription pluripotent properties.
format Online
Article
Text
id pubmed-10656071
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-106560712023-11-17 DOT1L is a barrier to histone acetylation during reprogramming to pluripotency Wille, Coral K. Zhang, Xiaoya Haws, Spencer A. Denu, John M. Sridharan, Rupa Sci Adv Biomedicine and Life Sciences Embryonic stem cells (ESCs) have transcriptionally permissive chromatin enriched for gene activation–associated histone modifications. A striking exception is DOT1L-mediated H3K79 dimethylation (H3K79me2) that is considered a positive regulator of transcription. We find that ESCs are depleted for H3K79me2 at shared locations of enrichment with somatic cells, which are highly and ubiquitously expressed housekeeping genes, and have lower RNA polymerase II (RNAPII) at the transcription start site (TSS) despite greater nascent transcription. Inhibiting DOT1L increases the efficiency of reprogramming of somatic to induced pluripotent stem cells, enables an ESC-like RNAPII pattern at the TSS, and functionally compensates for enforced RNAPII pausing. DOT1L inhibition increases H3K27 methylation and RNAPII elongation–enhancing histone acetylation without changing the expression of the causal histone-modifying enzymes. Only the maintenance of elevated histone acetylation is essential for enhanced reprogramming and occurs at loci that are depleted for H3K79me2. Thus, DOT1L inhibition promotes the hyperacetylation and hypertranscription pluripotent properties. American Association for the Advancement of Science 2023-11-17 /pmc/articles/PMC10656071/ /pubmed/37976354 http://dx.doi.org/10.1126/sciadv.adf3980 Text en Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Biomedicine and Life Sciences
Wille, Coral K.
Zhang, Xiaoya
Haws, Spencer A.
Denu, John M.
Sridharan, Rupa
DOT1L is a barrier to histone acetylation during reprogramming to pluripotency
title DOT1L is a barrier to histone acetylation during reprogramming to pluripotency
title_full DOT1L is a barrier to histone acetylation during reprogramming to pluripotency
title_fullStr DOT1L is a barrier to histone acetylation during reprogramming to pluripotency
title_full_unstemmed DOT1L is a barrier to histone acetylation during reprogramming to pluripotency
title_short DOT1L is a barrier to histone acetylation during reprogramming to pluripotency
title_sort dot1l is a barrier to histone acetylation during reprogramming to pluripotency
topic Biomedicine and Life Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656071/
https://www.ncbi.nlm.nih.gov/pubmed/37976354
http://dx.doi.org/10.1126/sciadv.adf3980
work_keys_str_mv AT willecoralk dot1lisabarriertohistoneacetylationduringreprogrammingtopluripotency
AT zhangxiaoya dot1lisabarriertohistoneacetylationduringreprogrammingtopluripotency
AT hawsspencera dot1lisabarriertohistoneacetylationduringreprogrammingtopluripotency
AT denujohnm dot1lisabarriertohistoneacetylationduringreprogrammingtopluripotency
AT sridharanrupa dot1lisabarriertohistoneacetylationduringreprogrammingtopluripotency